Brief: Xspray Pharma Q1 Pretax Loss Widens To SEK 18.9 Mln
06/05/2022 07:38
May 6 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* Q1 PRETAX LOSS SEK 18.9 MILLION VERSUS LOSS 13.9 MILLION
YEAR
AGO
Source text for Eikon: ID:nMFN7Bnvz9
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003